Abraham, P., Yue, H., & Wilson, L. (2010). Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-Related Macular Degeneration: PIER Study Year 2. American journal of ophthalmology, 150(3), 315-324.e1. https://doi.org/10.1016/j.ajo.2010.04.011
Citácia podle Chicago (17th ed.)Abraham, Prema, Huibin Yue, a Laura Wilson. "Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-Related Macular Degeneration: PIER Study Year 2." American Journal of Ophthalmology 150, no. 3 (2010): 315-324.e1. https://doi.org/10.1016/j.ajo.2010.04.011.
Citácia podľa MLA (8th ed.)Abraham, Prema, et al. "Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-Related Macular Degeneration: PIER Study Year 2." American Journal of Ophthalmology, vol. 150, no. 3, 2010, pp. 315-324.e1, https://doi.org/10.1016/j.ajo.2010.04.011.